Biotechnology News

September 16, 2014

HARTFORD, Conn.--(BUSINESS WIRE)--The Coalition Against Lyme and Related Borrelioses today called for DNA tests for faster, more reliable and effective testing for Lyme disease and related tick borne illnesses for better patient care.

September 16, 2014

MOUNT ARLINGTON, N.J.--(BUSINESS WIRE)--PDS, a leading global provider of intuitive data management software and solutions for life sciences research, announces that a top 5 pharma company has used TranSEND™ to successfully submit multiple SEND...

September 16, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios was awarded a NIH grant to develop a process for manufacturing cGMP cannabidiol (CBD) using its green drug manufacturing technology for clinical evaluation by NIH and other investigators.

September 16, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services, announced the completion of enrollment of a human abuse liability (HAL) clinical trial of centranafadine...

September 16, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs Announces Crucial New Tool for Impaired Driving Investigation

September 16, 2014

BOSTON--(BUSINESS WIRE)--Halloran Consulting Group, Inc. (Halloran) today announced they have relocated from Waltham, MA to the Fort Point District of downtown Boston. With fortuitous timing, Halloran has simultaneously been recognized by Inc....

September 16, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB:TRGM), is scheduled to present the latest in therapeutic nutrition and medical food at SACHS Associated 14th Annual Biotech Europe Forum in Basel, Switzerland.

September 16, 2014

LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev and its President/CEO Ibraheem Mahmood are finalists for the SCRIP Awards. DrugDev provides technology-driven solutions to help investigators, sponsors and CROs do more clincal trials.

September 16, 2014

MONTREAL--(BUSINESS WIRE)--The interim analysis for THR-184 for acute kidney injury has been successfully completed. Thrasos announced that 200 patients have been enrolled to date in the clinical trial.

September 16, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Vikas Sharma, PhD, Director of...

September 16, 2014

FLORENCE, Italy--(BUSINESS WIRE)--CSL Behring announced today that the last patient has been treated as part of the REPLACE (Randomized Evaluation of fibrinogen versus PLACEbo in complex cardiovascular surgery) Phase III clinical trial. REPLACE...

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that the peer-reviewed journal Virology has published...

September 16, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix today announced that Dr. Mark Roskey has joined Quanterix' leadership team as Vice President and General Manager, Applications and Reagents.

September 16, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostic company focused on spine imaging informatics, announced today that it has entered into an agreement with Medtronic, giving Medtronic the ability...

September 16, 2014

TOREKOV, Sweden--(BUSINESS WIRE)--Nolato AB (STO:NOLAB) Nolato Medical Pharma Packaging now have the ability to print Braille, or other offset surface print, directly onto plastic containers. The process developed by Nolato Jaycare in the UK...

September 16, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Morrisville, NC, September 16, 2014 – Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) announces new company name and symbol effective September 19, 2014: Tenax Therapeutics Inc. (NASDAQ:TENX).

September 16, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock

September 16, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV) is extremely pleased to report that analysis of the interim data from the first 13 patients in a Phase I clinical trial show that each of the patients treated have raised specific T-cell...

September 16, 2014

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis has been named among the top 10 on Working Mother magazine’s "100 Best Companies for Working Mothers" list

September 16, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has appointed three new members to its Scientific Advisory Board: Dr. Andrea Califano, Dr. Arnold J. Levine and Dr. Aviv Regev. Dr....

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today new pre-clinical results with ALN-CC5, a subcutaneously administered RNAi therapeutic targeting complement...

September 16, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer

September 16, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics has appointed Mary Wadlinger to its executive leadership team as Senior Vice President, Human Resources. She joins FORMA from Millennium Pharmaceuticals.

September 16, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma announced that a joint LabCorp/ARCA personalized medicine abstract was presented yesterday evening at the 18th Annual Scientific Meeting of the Heart Failure Society of America.

September 16, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--The Clatterbridge Cancer Centre, Edinburgh Cancer Centre and The Christie at Salford Royal, comply with a quality program for precision radiation treatment established by an international consortium.

September 16, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech announced that a subgroup analysis assessing the development and progression of sub-retinal fibrosis in the Company's Phase 2b trial will be presented at the AAO 2014 Meeting in Chicago.

September 16, 2014

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere closed with $2 million in funding based on the strength of its DNA-based targeted drug delivery platform, which is being used in more than 25 collaborations.

September 16, 2014

WASHINGTON--(BUSINESS WIRE)--CeloNova BioSciences announces First-in-Man clinical trial results found its COBRA PzF™ coronary stent system a safe/effective routine treatment for real-world and complex heart disease patients.

September 16, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq(TM) (belinostat) for Injection with Patent Term Adjustment till 2027

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ: XLRN) announces series of online educational seminars with thought-leading experts in diseases for which sotatercept and luspatercept (ACE-536) are being developed.

September 16, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that the U.S. Patent and...

September 16, 2014

EMERYVILLE, CA--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that the company will be...

September 16, 2014

NEW YORK--(BUSINESS WIRE)--SIGA Technologies, Inc. (NASDAQ:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced today that it has filed a voluntary petition...

September 16, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer

September 16, 2014

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company today presented results from a 52-week Phase III study that demonstrated sustained efficacy of the investigational empagliflozin/linagliptin...

September 16, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono today announced the establishment of a long-term strategic partnership with Lupin Limited. Lupin will support Merck Serono in the implementation of their General Medicines portfolio.

September 16, 2014

ABERDEEN, Scotland--(BUSINESS WIRE)--NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company (“NovaBiotics” or the “Company”), today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for...

September 16, 2014

HELSINKI--(BUSINESS WIRE)--The Ginolis Delilah™ lateral flow assembly (LFA) product is built on the Ginolis’s productized modular Ginolis Delilah™ robotic platform, which has a proven track record for various Point of Care (POC) diagnostic...

September 16, 2014

AMSTERDAM--(BUSINESS WIRE)--In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific...

September 16, 2014

OXFORD & NEWCASTLE, United Kingdom--(BUSINESS WIRE)--e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces its half year results for the six months ended 31 July 2014.

September 16, 2014

SEOUL, South Korea--(BUSINESS WIRE)--Panagene has been in focus on news of having developed a commercial ctDNA test kits that can detect mutated oncogene through blood test alone. This technology is based on PNA (Peptide Nucleic Acid) and it can...

September 16, 2014

CAMBRIDGE, Mass. & BRISBANE, Queensland--(BUSINESS WIRE)--Vaxxas announced the initiation of a research project to evaluate Vaxxas' proprietary Nanopatch™ platform for delivery of polio vaccine, funded by the World Health Organization (WHO...

September 16, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Data show that pulmonary artery pressure monitoring reduced HF hospitalization in patients with kidney failure by 42% compared to standard care alone and didn't adversely affect kidney function.